Skip to content
Recall Observatory FDA recall evidence

Drug product

Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA 68875-0205-02

D-0038-2020

September 12, 2019

Class I

Product summary

Firm
Shire Human Genetic Therapies, Inc.
Event
Event 83792
Status
Terminated
Classification
Class I
Quantity
8,003
Official record key
drug-enforcement:D-0038-2020

Official wording

Reason: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing

Code information: 06828752, exp 12/31/2019 07110118, exp 4/30/2021 07164107, exp 12/31/2019 07200436, 07301074, exp 4/30/2021 07482212, 07630715, exp 6/30/2021 07769460, exp 4/30/2021

Distribution pattern: Product was distributed throughout the United States.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing